Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Wallaby Medical

Request full access

Emerging medical device company focused on developing therapies for vascular disease

Laguna Hills, United StatesFounded 2015Biotech & Life Sciences

About Wallaby Medical

Wallaby Medical is a medical device company focused on developing and commercializing technologies for the treatment of strokes. The company was founded in December 2015 by Michael Alper and Bing Liu, who serve as CEO and Chairman, respectively. Michael Alper, originally from New York with a background in computer science, transitioned to the medical device industry after his MBA, working at Medtronic in Asia before starting Wallaby. His experience in the Asian market highlighted the high incidence of stroke among East Asian populations, which became a key motivator for the company's mission.

The company's business is centered on the design, manufacturing, and sale of neurovascular interventional products used to treat both ischemic and hemorrhagic strokes. Its clients are hospitals and medical professionals specializing in neurovascular procedures. Wallaby Medical operates globally, with a strong presence in the United States, China, Europe, and Japan, and its products are sold in over 60 countries. The company's revenue is generated through the sale of its medical devices. A significant milestone was the acquisition of phenox GmbH, a German neurovascular company, in April 2022 for approximately €500 million. This acquisition, which included phenox's sister company femtos GmbH, significantly expanded Wallaby's product portfolio and geographic footprint, combining complementary technologies with no product overlap.

Wallaby Medical's product portfolio includes the Avenir® Coil System, a neuro embolic coil system for treating intracranial aneurysms, which has received FDA, CE Mark, and Japan PMDA approval. The company also offers the Esperance™ Aspiration Catheter for ischemic stroke treatment, which is cleared in the U.S. and China. Through the phenox acquisition, the company's offerings grew to include the pRESET® series of stent retrievers for mechanical thrombectomy and the p64/p48 Flow Modulation Devices for treating intracranial aneurysms, both approved in Europe. The combined entity now boasts a comprehensive product line for stroke care, supported by 5 R&D centers and 3 production bases worldwide.

Source: Dealroom company data

At a glance

Status
Operational
Employees
26
Open positions
None listed
Dealroom signal
32.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Apr 2022
Capital deployed
—
Preferred round
ACQUISITION

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Mar 2026 $0 — Undisclosed ↗
LATE VCOther financing Mar 2026 $0 — Hillhouse Capital · Qianhai Ark Asset Management · Yingmai Medical · Gaorong Capital ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Wallaby Medical website traffic

Latest recorded traffic for Wallaby Medical is 990 monthly website visits, down 61.9% over the last three months. Wallaby Medical's team declined 10.3% over the past year.

Latest monthly visits990 3-month web change-61.9% 1-year team growth-10.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
AirBiometricsHelps to regain sovereignty over well-being Castellón de la Plana, Spain Operational 8 $220K $880K
Gemina LabsDeveloped and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals Calgary, Canada Operational
SentanteDeveloping a radiation-reducing manipulator and a minimally invasive coronary robotic system for endovascular procedures Kaunas, Lithuania Operational
SapphirosConsumer diagnostics company offering rapid, at-home tests for infectious diseases and personalized wellness insights Boston, United States Operational
AntegenesGenetic tests for personalized cancer risk prevention Tartu, Estonia Operational
ExogeneBiotechnology company accelerating target and TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening Oxford, United Kingdom Operational
ElectroCoreHelping patients across the globe who suffer from pain and chronic conditions by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments Rockaway Township, United States Operational
AccexibleDeveloping a speech analysis platform based on AI models to early detect diseases as dementia, Parkinson, and coronary disease Bilbao, Spain Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Wallaby Medical in the Laguna Hills ecosystem

Live from Dealroom

The Wallaby Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • CD Capital

Series A4 investors entered at this stage

  • CITIC Medical
  • Qianhai FOF
  • Maison Capital
  • Chang 'an Capital

Series B and later8 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States64.3%
🇨🇳 China35.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Wallaby Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Wallaby Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.